Following the success of our inaugural event in May 2017, and an overwhelming demand to host a second roundtable workshop, we were pleased to host our second invitation-only event “Patient-Centered Drug Development: Reflections, Challenges, & Solutions” on November 8th, 2017 at the Glasgow Science Center, Glasgow, Scotland. During this exclusive event we brought together strategic decision-makers to share their experience and discuss a roadmap for success.

We were delighted to be joined by guest speakers Professors John Browne and Anna Mayhew, and Dr Jean-François Ricci. Professor Browne presented on the efficient use of PROMs in a real-world setting, Professor Mayhew spoke about her experience in clinical trials in paediatric rare diseases, and Dr Ricci summarised his views on the current challenges for HTA. Finally, our own Dr Stefan Cano talked about facing the challenges of patient-centered outcome measurement, including interpretability, legacy instruments, and treatment benefit. During this lively interactive morning, all participants were given the opportunity to ask questions and put forward their views about how best to advance the measurement of patient-centered outcomes.

Given another great success, we fully intend on having a third event in Baltimore in May 2018. If you are interested in attending, please let us know. If the last two events are anything to go by, seats will go very quickly. So please book early!